- £161.26bn
- £179.84bn
- $54.07bn
- 86
- 16
- 74
- 64
REG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Lynparza & Imfinzi positive CHMP in endometrial
AnnouncementRCS - Redx Pharma plc - Redx Reports Encouraging Zamaporvint Phase 2 Data
AnnouncementREG - AstraZeneca PLC - Update on Imfinzi ADJUVANT BR.31 trial
AnnouncementREG - AstraZeneca PLC - Imfinzi improved EFS and OS in bladder cancer
AnnouncementREG - AstraZeneca PLC - Update on CAPItello-290 Phase III trial
AnnouncementREG - AstraZeneca PLC - Imfinzi approved in the US for endometrial cancer
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Acquisition of Fusion completed
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Tagrisso plus chemo recommended for approval in EU
AnnouncementREG - AstraZeneca PLC - Dato-DXd improved OS in nonsquamous lung cancer
AnnouncementREG - AstraZeneca PLC - AstraZeneca to deliver $80bn revenue by 2030
AnnouncementREG - AstraZeneca PLC - AstraZeneca to manufacture ADCs in Singapore
AnnouncementREG - AstraZeneca PLC - SUPERNOVA Trial Met COVID-19 prevention endpoint
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AstraZeneca completes Cellectis equity investment
AnnouncementREG - AstraZeneca PLC - Calquence combination improved PFS in 1L MCL
Announcement